Michael Baxter, MD, MSC | |
Psc 475 Box 1852, Fpo, AP 96350-1852 | |
(619) 532-9600 | |
Not Available |
Full Name | Michael Baxter |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Location | Psc 475 Box 1852, Fpo, Armed Forces Pacific |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972863884 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 0101258850 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michael Baxter, MD, MSC Nmcsd, 34520 Bob Wilson Dr., Suite 200, San Diego, CA 92134-0001 Ph: () - | Michael Baxter, MD, MSC Psc 475 Box 1852, Fpo, AP 96350-1852 Ph: (619) 532-9600 |
News Archive
The March of Dimes Foundation, the Partnership for Maternal, Newborn & Child Health, Save the Children, and the WHO on Wednesday released a new report, titled "Born Too Soon: The Global Action Report on Preterm Birth," showing that 15 million infants are born prematurely each year, 1.1 million of those infants die, but 75 percent of those deaths are preventable.
A commonly used class of biologic response modifying drugs can cause acute liver injury with elevated liver enzymes, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.
Investigators found similarities in the bacterial composition of the mouth among patients with early rheumatoid arthritis and those at risk of developing the disease, compared with healthy individuals who were not at risk. The findings come from a study published in Arthritis & Rheumatology.
If you're one of Australia's 1.4 million shift workers, you'll know that managing irregular hours can be hard, disrupting normal eating and sleeping patterns, and reducing the opportunity for regular exercise.
Paladin Labs Inc. and Labopharm Inc. announced today that they have entered into a definitive agreement pursuant to which Paladin will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash, which represents a premium of 57.4% over the volume-weighted average price of Labopharm's shares of $0.1815 for the 30 trading days prior to this announcement.
› Verified 7 days ago
Dr. Jason Maurice Wray Ii, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: Nmrtc Okinawa, Psc 482, Fpo, AP 93632 Phone: 315-646-7035 | |
Christopher Hill, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Fpo, AP 96362 Phone: 800-538-9552 |